Prospective evaluation of hematological parameters in preoperative renal cell cancer patients.

Published in: BMC urology (2022)

The preoperative FAR is an independent prognostic factor of OS in renal cancer patients. A FAR > 0.114 was significantly related to decreased survival in renal cancer patients. In addition, the platelet-lymphocyte ratio seems to be related to OS, as well as FAR. Further studies are required on this subject.

Keyphrases

prognostic factors
patients undergoing
single cell
cell therapy